Artificial heart maker Carmat to launch capital increase soon (updated)

Carmat SA

15/01/2024 06:38

(Adds annual revenue, outlook, manufacturing capacity from
paragraph 2)
       PARIS, Jan 15 (Reuters) - French artificial heart maker
Carmat  ALCAR.PA  said on Monday that it would soon launch a
capital increase, estimated to raise at least 50 million euros
($54.8 million), to ensure it had enough financing for the next
12 months.
    Carmat, which survived a cash crunch in mid-October, said it
had generated annual revenue of 2.8 million euros. 
    This corresponds to the sale of 17 of its Aeson prostheses,
including 11 in the last quarter of 2023, confirming it
accelerated the pace of implants.
    It also said it sees sales between 14 million and 20 million
euros in 2024.
    The company confirmed its previously announced target to
increase its manufacturing capacity to 500 hearts per year from
early 2024, with the opening of a second production facility in
Bois-d'Arcy. 
 ($1 = 0.9123 euros)

 (Reporting by Sudip Kar-Gupta in Paris, Michal Aleksandrowicz
in Gdansk; Editing by Edmund Klamann)
 ((sudip.kargupta@thomsonreuters.com;))